Valplast Technologies was incorporated on January 10, 2014. The company is a civil engineering and construction firm specialising in structural waterproofing systems, injection grouting, and infrastructure projects such as tunnels, dams, reservoirs, canals, and buildings. It has expanded into tunnel construction, pre-cast concrete structures, and MEP services, executing projects mainly through sub-contracts in defence, railways, and civil sectors, with some direct contracts for private and government clients
| Bidding Dates |
|---|
| 29 Sep 2025 - 01 Oct 2025 |
| Subscription |
|---|
| 1.35x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹2,80,000 | 2 | 2 | 4000 | 5.5 M | ₹35 | 56.25 % | ₹192.5 M | RHP DOC |
VijayPD Ceutical IPO SUBSCRIPTION STATUS
01 Oct '25VijayPD Ceutical IPO overall subscription rate was 1.35 times the total available shares
VijayPD Ceutical IPO retail subscription rate was 0.84 times in the retail segment
VijayPD Ceutical IPO non-institutional investor subscription rate was 1.86 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
01 Oct 2025 (Day 3) | 0.84x | 1.86x | - |
30 Sep 2025 (Day 2) | 0.27x | 1.69x | - |
29 Sep 2025 (Day 1) | 0.07x | 1.05x | - |
VijayPD Ceutical FINANCIALS
| Period | Revenue from Operations (Rs in crore) | Net Profit (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY25 | 63.2 | 6.1 | 1.0 | -9.7 | 20.1% |
| FY24 | 64.9 | 6.5 | 1.8 | 0.1 | 15.4% |
| FY23 | 27.2 | 1.3 | -1.7 | -3.1 | 11.5% |
VijayPD Ceutical IPO SUBSCRIPTION STATUS DETAILS
VijayPD Ceutical had 5.5 M shares on offer
VijayPD Ceutical IPO offer price was ₹35
VijayPD Ceutical IPO minimum Investment was ₹280000
VijayPD Ceutical IPO issue size was ₹ 192.5 M
VijayPD Ceutical had a minimum lot size of 4000 Shares per application
VijayPD Ceutical NUMBER OF SHARES ON OFFER
VijayPD Ceutical IPO IMPORTANT DATES
| Issue Open Date | 29 Sep 2025 |
| Issue close Date | 01 Oct 2025 |
| Allotment Date | 03 Oct 2025 |
| Refund Date | 06 Oct 2025 |
| Demat Account Credit Date | 06 Oct 2025 |
| Listing Date | 07 Oct 2025 |
| Listing on Exchange(s) | NSE |
| VijayPD Ceutical Allotment Status | Exchange/ Registrar |
VijayPD Ceutical IPO subscription opened on 29 Sep 2025, and closed on 01 Oct 2025
IPO allotment for VijayPD Ceutical was finalized on Friday, 03 Oct 2025
IPO listing for VijayPD Ceutical was on NSE on Tuesday, 07 Oct 2025
VijayPD Ceutical IPO LISTING GAINS
| Issue Price (adjusted) | 35.0 |
| Listing Open Price | 35.0 |
| Listing Close Price | 35.9 |
| Listing Gain% | 0.0% |
| Current Gain% | 82.9% |
VijayPD Ceutical Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VijayPD Ceutical Ltd. | 64 | 125 | 25 | 1.2 | 9.5 | 5 | 104.4 | 5 | 2.6 | ||||
| Dr. Lal Pathlabs Ltd. | 1954 | 32797.7 | 60.5 | 10.8 | 11.3 | 20.1 | 16 | 2864.2 | 12.1 | 504.8 | 3.6 | 32.3 | 5.6 |
| Inventurus Knowledge Solutions Ltd. | 1728.8 | 29661.6 | 38.8 | 0.9 | 8.9 | 25.8 | 16.9 | 3211 | 18.8 | 721.6 | 48.4 | 44.5 | 40.9 |
| Vijaya Diagnostic Centre Ltd. | 1392.6 | 14343.5 | 76.5 | 3.1 | 16.7 | 18.1 | 11.5 | 835 | 19.3 | 173 | 20.9 | 18.2 | 24.9 |
| Indegene Ltd. | 568.8 | 13702 | 34.2 | -4.3 | 3.6 | 12.8 | 8.7 | 3582.5 | 21.6 | 401.1 | -1.4 | 16.6 | -7.9 |
| Metropolis Healthcare Ltd. | 572.6 | 11876.1 | 58.9 | 1.8 | 6.9 | 12.6 | 8.9 | 1671.4 | 24.1 | 190 | 31.1 | 9.7 | 32.6 |
VijayPD Ceutical INFORMATION ON IPO ISSUE
About VijayPD Ceutical
Valplast Technologies was incorporated on January 10, 2014. The company is a civil engineering and construction firm specialising in structural waterproofing systems, injection grouting, and infrastructure projects such as tunnels, dams, reservoirs, canals, and buildings. It has expanded into tunnel construction, pre-cast concrete structures, and MEP services, executing projects mainly through sub-contracts in defence, railways, and civil sectors, with some direct contracts for private and government clients
Object of the Issue
- Funding the capital expenditure requirements of the company by purchase of plant and machinery
- Funding the working capital requirement of the company
- To meet out the general corporate purposes
VijayPD Ceutical - PROMOTERS
| Name |
|---|
| Samit Madhukar Shah |
| Bhavin Dhirendra Shah |
| Rahul Jitendra Shah |
| Narendra Nagindas Shah |
| Dina Madhukar Shah |
| Vasanti Dhirendra Shah |
| Hemanti Jitendra Shah |
VijayPD Ceutical - MANAGEMENT & LEADERSHIP
| Name | Designation |
|---|---|
| Samit Madhukar Shah | Chairman & Managing Director |
| Bhavin Dhirendra Shah | Whole Time Director |
| Rahul Jitendra Shah | Whole Time Director |
| Narendra Nagindas Shah | Non - Executive Director |
| Nikita H Pedhdiya | Non-Executive Independent Director |
| Pulkit Gopal Prasad Agrawal | Non-Executive Independent Director |
VijayPD Ceutical Book Running Lead Manager
Smart Horizon Capital Advisors Private Limited
director@shcapl.com
VijayPD Ceutical Registrar to the issue
Kfin Technologies Limited
vcl.ipo@kfintech.com
VijayPD Ceutical Strengths
Comprehensive product portfolio
The company’s pharmaceutical distribution network covers generic and branded drugs, wellness, OTC, baby, and food products, along with specialised medicines across multiple therapies. With strong inventory management, efficient ordering, competitive pricing, and robust logistics, it effectively serves diverse healthcare needs
Streamlined supply chain management
The company’s efficient supply chain reduces lead times, lowers inventory costs, and boosts responsiveness to market changes. This streamlined system gives it a strong competitive edge in pharmaceutical distribution, ensuring timely delivery, quality products, and improved customer satisfaction
VijayPD Ceutical Risks
Non-compliance risks
The company faces risks from distributing expired, defective, or damaged healthcare products. Non-compliance with quality standards or product returns could lead to financial losses, liability claims, and reputational damage
Expansion risks
The company’s growth depends on efficiently operating and expanding its supply chain and distribution network for healthcare products in Mumbai and Maharashtra. Poor coordination among suppliers, transporters, and employees could hinder operations and negatively impact business and financial performance
Regulatory risks
The company operates in a highly regulated industry, relying on approvals and permits from central, state, and local authorities. Delays, failures, or regulatory changes could affect business operations, strategy, profitability, and compliance requirements
IPO FAQs
The promoters of the company are Samit Madhukar Shah, Bhavin Dhirendra Shah, Rahul Jitendra Shah, Narendra Nagindas Shah, Dina Madhukar Shah, Vasanti Dhirendra Shah and Hemanti Jitendra Shah.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 35.0 - 35.0.
The IPO application opens on Sep 29, 2025 and closes on Oct 01, 2025.
The minimum lot size for the IPO is 8000. The maximum lot size for the IPO is 8000.
For all category investors, the minimum application amount for this IPO is Rs. 280,000.0, the maximum value for this IPO is Rs 280,000.0.
This IPO will be allotted on Oct 03, 2025.
The refund will be credited to your account on Oct 06, 2025.
The allotted shares will be credited to your demat on Oct 06, 2025.
Vijaypd Ceutical Ltd.’s shares listed on the stock exchanges on Oct 07, 2025.